image: Dr. Felipe Sierra, Chief Science Officer, Hevolution Foundation
Credit: Hevolution Foundation
BOSTON, United States — 29 March, 2024 — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research. The major goal is to identify and support research that will further the Hevolution’s mission of extending healthy lifespan for the benefit of all humanity.
HF-GRO will provide up to $25 million in 2024 (the total budget planned over 5 years is $115M) to fund approximately 40-60 projects in aging biology or geroscience. Preference, both in length and funding level, will be given to projects that advance basic biology knowledge towards translation (geroscience).
HF-GRO provides support for research projects in the basic biology of aging, as well as projects that translate advances in basic research from the laboratory towards the clinic (translational geroscience). Work should focus on strategies to improve healthy aging by addressing basic principles of aging biology and geroscience. Projects that deal strictly with clinical problems such as the diagnosis or treatment of disease, or the social context of aging are not eligible. Therefore, this initiative will support research approaches that addresses:
- The maintenance and/or improvement of the mechanisms underlying aging
- How this might improve health and delay/improve the outcome of age-related diseases and conditions
The Letter of Intent submission deadline for the 2024 program is April 26, 2024. For more information, grant program guidelines, and to submit an application, visit: www.hevolution.com/funding-opportunities
About Hevolution Foundation
Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub in Boston and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer. To date, Hevolution has committed $250 million to drive scientific discoveries to make aging healthier for humanity.
Learn more at: https://hevolution.com/ and connect with us on LinkedIn